Pacific Biosciences of California Overview
Pacific Biosciences of California Target Price
Analysts' 12-month price predictions for PACB.
Share Price
$2.02
Average Target Price
$2.80
38.6% upside
38.6% upside5 analysts in the last 4 months
High: $4 | Low: $2
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2024-05-13 | Morgan StanleyTejas Savant | $4 | 98% upside |  |
| 2024-05-13 | Piper SandlerDavid Westenberg | $2 |  1% downside | |
| 2024-05-10 | BarclaysLuke Sergott | $2 | 1% downside | |
| 2024-04-18 | Goldman SachsMatthew Sykes | $2.5 | 23.8% upside | |
| 2024-04-16 | Canaccord GenuityKyle Mikson | $3.5 | 73.3% upside | |
| 2022-11-16 | Canaccord Genuity | $14 | 593.1% upside | |
| 2022-08-17 | Piper SandlerDavid Westenberg | $7.5 | 271.3% upside | |
| 2022-05-15 | Piper SandlerDavid Westenberg | $6 | 197% upside | |
| 2022-01-12 | Piper SandlerDavid Westenberg | $20 | 890.1% upside | |